Le Mans, France

Arnaud Nourry

USPTO Granted Patents = 6 


 

Average Co-Inventor Count = 8.0

ph-index = 5

Forward Citations = 81(Granted Patents)


Location History:

  • Sutton, GB (2011)
  • Les Mans Cedex, FR (2012)
  • Le Man Cedex 9, FR (2013)
  • Le Mans Cedex 9, FR (2014)
  • Le Mans Cedex, FR (2015)
  • Le Mans, FR (2017)

Company Filing History:


Years Active: 2011-2017

Loading Chart...
Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: **Arnaud Nourry: Innovator in Cancer Therapeutics**

Introduction

Arnaud Nourry, based in Le Mans, France, is a notable inventor with a focus on therapeutic compounds aimed at addressing proliferative disorders, including cancer. With a total of six patents to his name, his innovative contributions to cancer research are significant for the medical field.

Latest Patents

Nourry's latest patents include the development of pyrido[2,3-b]pyrazin-8-substituted compounds. These compounds are designed to inhibit RAF (e.g., B-RAF) activity, which plays a critical role in cancer cell proliferation. The invention not only covers the compounds themselves but also pharmaceutical compositions that utilize these compounds for in vitro and in vivo applications. The potential uses of these compounds include managing diseases such as colorectal cancer and melanoma, as they target receptor tyrosine kinase (RTK) activity and impede cell proliferation.

Career Highlights

Throughout his career, Nourry has been associated with leading organizations, notably Cancer Research Technology Limited and the Institute of Cancer Research: Royal Cancer Hospital. His work in these institutions has shaped his research direction and focus on innovative cancer therapies.

Collaborations

Nourry has collaborated with several prominent individuals in the field, including Dan Niculescu-Duvaz and Caroline Joy Springer. These partnerships have enhanced his research and development efforts, enabling collaborative innovation in cancer treatment solutions.

Conclusion

Arnaud Nourry stands as a significant figure in the realm of cancer therapeutics, demonstrating a commitment to innovation through his patents and collaborative endeavors. His work has the potential to impact treatment modalities for cancer, providing hope for those affected by proliferative disorders.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…